Rezolute, Inc. (RZLT)
NASDAQ: RZLT · IEX Real-Time Price · USD
4.210
-0.100 (-2.32%)
At close: Jul 2, 2024, 4:00 PM
4.340
+0.130 (3.09%)
After-hours: Jul 2, 2024, 6:58 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $216.34 million as of July 2, 2024. Its market cap has increased by 164.47% in one year.
Market Cap
216.34M
Enterprise Value
138.68M
1-Year Change
164.47%
Ranking
Category
Stock Price
$4.21
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $216.34M, an increase of 29.54%. That is a compound annual growth rate of 7.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 173.00M | 340.20% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ESSA Pharma | 218.71M |
| Zura Bio | 218.44M |
| Inovio Pharmaceuticals | 218.43M |
| Atai Life Sciences | 217.63M |
| Gossamer Bio | 217.12M |
| Q32 Bio | 215.55M |
| Nektar Therapeutics | 215.30M |
| Fractyl Health | 212.66M |